MSP Procurement extended till July 8; 6.18 Lakh PMAY-G houses cleared for UP (See 'Corp Brief') ICAR and APEDA Sea Protocol cuts Mango Export Cost (See 'Corp Brief') APEDA facilitates First Shipment of Premium Banganapalle Mangoes to Singapore (See 'Corp Brief') Cooperative banks must adopt modern tech platforms to remain relevant: Secy (See 'Corp Brief') APEDA facilitates First Biscuit Export Shipment from Varanasi to Oman (See 'Corp Brief') FEMA - Statutory protection under Section 6(4) cannot be invoked to legitimise unexplained or inadequately accounted foreign exchange transactions: SAFEMA (See 'Legal Desk') Vande Mataram Camp commences at Brainware University, West Bengal (See 'Corp Brief') Digitalization no longer a Choice, but Steel Sector's Survival Strategy: Kumaraswamy (See 'Corp Brief') IP 2026 establishes Standards for Blood and Blood Components (See 'Corp Brief') Ministry of Coal organises BRICS Side Event on Clean Coal Technologies (See 'Corp Brief') SEBI - Failure to file Quarterly Activity Reports for multiple consecutive quarters constitutes violation of regulatory framework & attracts consequences prescribed under Regulation 35 of AIF Regulations, 2012: SEBI (See 'Legal Desk') 100 Startups from 22 States complete Export-Focused Acceleration Programme (See 'Corp Brief') MoS pitches 'BRICS Space Economy' (See 'Corp Brief') IPC successfully conducts Training on Ethylene Glycol & DEG in Preparations by Gas Chromatography (See 'Corp Brief') Unlocking Potential of Idle Financial Assets in India (See 'Corp Brief') SARFAESI - In absence of any adjudication by the DRT in determining the debt, statutory scheme permits reliance upon claim made by secured creditor for purpose of fixing pre-deposit: HC (See 'Legal Desk') CCI okays acquisition of shares in Nxtra Data by Alpha Wave Ventures (See 'Corp Brief') CCI okays acquisition of 21% voting interest in Astemo Ltd. by Honda Motor (See 'Corp Brief') FEMA - Claims & liabilities pertaining to periods prior to approval of resolution plan, which do not survive under approved plan, are extinguished & cannot be enforced: SAFEMA (See 'Legal Desk') Special Drive launched for expeditious Disposal of Long-Pending Labour Cases (See 'Corp Brief') Amit Shah to launch NAFED's auction portal 'NAFEX.in' (See 'Corp Brief') SEBI - A judicial pronouncement cannot ordinarily be modified or reviewed through post-disposal miscellaneous application; Tribunal becomes functus officio upon disposal of appeal: SAT (See 'Legal Desk') Railways approves Kavach Deployment Worth Rs.270 Crore on East Coast (See 'Corp Brief') DIBD and AISF sign MoU to promote Language Technology and Multilingual Innovation in Assam (See 'Corp Brief') IPR - Injunction allowed as defendant's adoption of marks is not honest or bona fide; marks are deceptively similar to plaintiff's registered trademark, such that an average consumer with imperfect recollection would likely be confused: HC (See 'Legal Desk') NMDC accelerates Digitalisation and Sustainable Mining to support 100 MTPA Vision (See 'Corp Brief') Union Minister sanctions over 42,000 houses in MP; 38,000 families perform grih pravesh (See 'Corp Brief') A&C - Where a Section 34 court has already examined the award, a possible alternative interpretation of the contractual clause is insufficient to justify interference: HC (See 'Legal Desk') Tech Innovation and disruption in Construction Industry (See 'CORP EINSICHT') Union Minister reviews Power Sector and Urban Development Schemes with Jharkhand Govt (See 'Corp Brief') APEDA facilitates First Export of fresh Uttarakhand Litchi to Italy (See 'Corp Brief') Trade Marks - Quasi-judicial authority cannot validly base its decision on grounds that were not specifically disclosed in SCN, thereby depriving noticee of an effective opportunity to respond: HC (See 'Legal Desk') Nadda calls for Push towards a TB-Free India (See 'Corp Brief') India must take control of security-related necessities to remain future-ready: RM (See 'Corp Brief') A&C - Financial hardship cannot justify payment of disputed amount linked to fulfilment of deliverable-based obligations: HC (See 'Legal Desk')

Print

Pharmacopoeia Commission organizes 5-Day Capacity Building Training

Published: May 19, 2026

By TIOLCorplaws News Service

NEW DELHI, MAY 19, 2026: THE Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H), Ministry of Ayush, is organizing a five-day Capacity Building Training Program from 18th to 22nd May 2026. The programme is being conducted for drug regulators, enforcement authorities, quality control personnel, technical experts, faculty members, government analysts, researchers and scientists working in the field of Ayurveda, Siddha, Unani and Homoeopathy (ASU&H) medicines.

The programme aims to strengthen the knowledge, technical skills and professional capabilities of stakeholders associated with the regulatory, academic, quality control and manufacturing sectors of ASU&H drug development.

The inaugural session of the programme was graced by Jaspal Kaur Pradyot, Chief Controller of Accounts, Ministry of Health & Family Welfare, as the Chief Guest. In her address, she appreciated PCIM&H for its significant contribution towards the development of quality standards for ASU&H drugs through the adoption of modern instruments and advanced scientific techniques. She also highlighted the rich heritage of AYUSH systems of medicine and their growing global acceptance and popularity.

Dr. Abdul Qayum, Director (Technical) & Deputy CEO, National Medicinal Plants Board, Ministry of Ayush, attended the programme as the Guest of Honour. He emphasized the international recognition of the pharmacopoeias and formularies developed by PCIM&H and noted the increasing global demand and acceptance of ASU&H systems of medicine.

Welcoming the dignitaries and participants, Dr. Raman Mohan Singh, Director, PCIM&H, provided an overview of the organization and highlighted its key activities in the standardization and quality control of ASU&H medicines.

During the five-day programme, participants will receive expert-led lectures on various important aspects including NABL Accreditation and Quality Management Systems (QMS), Good Manufacturing Practices (GMP), pharmacognostic, physico-chemical, phytochemical, microbiological and pharmacological evaluation of ASU&H drugs, standardization and quality control of herbal drugs, regulatory and pharmacopoeial aspects of ASU&H medicines, and shelf-life studies of ASU&H drugs.

Participants will also undergo hands-on laboratory training at PCIM&H and participate in field visits to leading ASU&H drug manufacturing units, including Dr. Willmar Schwabe India Pvt. Ltd., Noida, and Hamdard Laboratories India, Ghaziabad. These visits are aimed at providing practical exposure to modern technologies, manufacturing practices and quality assurance systems adopted in the industry.

The programme has attracted 28 participants from across the country representing a diverse range of institutions and organizations, including State Drug Controllers, Drug Inspectors, Professors, Faculty Members, Research Officers, AYUSH-accredited Drug Testing Laboratories, National Institutes and Research Centres such as the National Institute of Siddha, Chennai; Siddha Central Research Institute, Chennai; Central Drugs Laboratory, Kolkata; Regional Ayurveda Research Institute (CCRAS), Jammu and Jhansi; and ASU&H drug manufacturing units.

This Capacity Building Training Program is a significant initiative by PCIM&H aimed at promoting professional excellence and strengthening quality standards within the ASU&H sector. By equipping stakeholders with updated technical knowledge and practical expertise, the programme seeks to further reinforce India's leadership in the global regulation, standardization and development of traditional systems of medicine.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
tioltube
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.